“Automation has already been heavily utilized in many aspects of mAb manufacturing, such as process control, monitoring, and testing. Continued investment in automation will further reduce cost by ...

Seven leading biotech industry players have teamed up to create a fictitious monoclonal antibody (mAb) that will serve as a quality-by-design example for the industry. The newly formed consortium ...